SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
NRC Health Common Stock
NRC
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
Last trade$25.63
Day change-$0.70 (-2.66%)
Day range$25.41 – $26.58
Volume32,444
Market cap$559M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$558.76M
Price / earnings
91.11×
Price / book
-61.25×
Price / sales
3.89×
EV / sales
4.58×
EV / EBITDA
26.96×
Profitability
Earnings per share
$0.29
Return on assets
4.41%
Return on equity
-67.23%
Dividend yield
2.41%
Liquidity and leverage
Debt / equity
-11.28×
Current ratio
0.64×
Quick ratio
0.64×
Cash ratio
0.09×
Cash flow
Price / cash flow
23.51×
Price / free cash flow
30.29×
Free cash flow
$18.45M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for NRC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$38.4M
$35.39M
$34.8M
$35.19M
$34.61M
$34.04M
$33.55M
$36.91M
Cost of revenue
$15.38M
$13.56M
$13.65M
$13.94M
$12.4M
$12.97M
$13.06M
$14.35M
Gross profit
$23.02M
$21.83M
$21.16M
$21.26M
$22.2M
$21.06M
$20.49M
$22.56M
Selling, general and administrative
$12.05M
$22.95M
$13.42M
$14.45M
$12.27M
$17.73M
$10.36M
$11.45M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$14.11M
$25.07M
$15.59M
$16.59M
$14.47M
$19.48M
$11.9M
$12.97M
Operating income
$8.91M
-$3.24M
$5.57M
$4.67M
$7.74M
$1.59M
$8.6M
$9.59M
Interest expense
-$1.53M
-$1.32M
-$1.26M
-$1.37M
-$1.46M
-$1.03M
-$899K
-$729K
Income before taxes
$7.4M
-$4.54M
$4.38M
$3.27M
$6.27M
$581K
$7.72M
$8.88M
Income taxes
$2.7M
-$1.25M
$1.16M
$1.47M
$2.15M
$687K
$1.94M
$2.32M
Net income
$4.7M
-$3.28M
$3.22M
$1.8M
$4.12M
-$106K
$5.79M
$6.56M
Net income attributable to common shareholders
$4.7M
-$3.28M
$3.22M
$1.49M
$4.12M
-$106K
$5.79M
$6.56M
EBITDA
$10.98M
-$1.12M
$7.74M
$6.81M
$9.93M
$3.33M
$10.14M
$11.1M
Basic earnings per share
$0.22
-$0.15
$0.14
$0.07
$0.18
-$0.01
$0.25
$0.28
Diluted earnings per share
$0.21
-$0.15
$0.14
$0.07
$0.18
-$0.01
$0.25
$0.28
Recent news
Company coverage with links to the original publishers.
NRC Health reported Q3 2026 results showing 11% growth in total recurring contract value to $151.9M while maintaining 27% adjusted EBITDA margins despite heavy implementation spending. The company identified three key opportunities: contract value growth outpacing revenue as system implementations scale, 70% of customers using only one product offering massive expansion potential, and a 60% increase in sales pipeline amid competitor consolidation. Management expects margin expansion in H2 2026 as revenue reflects recent TRCV growth.
Lincoln, Nebraska, Nov. 17, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023.
LINCOLN, Neb., Nov. 07, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2023.
Lincoln, Nebraska, Oct. 24, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 third quarter earnings conference call on Wednesday, November 8, 2023. The Company’s results for the 2023 third quarter will be released after the close of the market on Tuesday, November 7, 2023.
LINCOLN, Neb., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce that Lurie Children’s Hospital of Chicago has expanded their long-time partnership to include NRC Health’s Market Insights, the nation’s most comprehensive and longest-running syndicated study of consumer perceptions in healthcare. As a valued partner utilizing NRC’s patient experience technology and expertise, Lurie Children’s has expanded their relationship to better understand their patients and the broader communities they serve.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.16 per share
Declared
Oct 14, 2026
Ex-dividend
Dec 29, 2026
Pay date
Jan 8, 2027
Ex-dividend
Amount / share
Pay date
Type
Sep 25, 2026
$0.16
Oct 9, 2026
recurring
Jun 26, 2026
$0.16
Jul 10, 2026
recurring
Mar 27, 2026
$0.16
Apr 10, 2026
recurring
Dec 26, 2025
$0.16
Jan 9, 2026
recurring
Sep 26, 2025
$0.12
Oct 10, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.